newsfilter
← Latest News
Business Wire·

Menarini Group Completes Acquisition of Stemline Therapeutics

FLORENCE, Italy--(BUSINESS WIRE)--Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics (Nasdaq: STML), for an aggregate cash consideration up to $677 million on a fully diluted basis.